Israel Chemicals Shs (ICL) Ex-Dividend Day Scheduled for June 03, 2016

Israel Chemicals Shs (ICL) Ex-Dividend Day Scheduled for June 03, 2016

Plantations International Monsanto News

< div id=”articleText” readability=”59.52″ > Israel Chemicals Shs (ICL) will start trading ex-dividend on June 03, 2016. A money dividend repayment of $ 0.02745 per share is arranged to be paid on June 22, 2016. Investors who bought ICL before the ex-dividend date are qualified for the money returns settlement. At the present stock cost of $ 4.16, the reward yield is 2.64%.

The previous trading day’s last sale of ICL was $ 4.16, representing a -43.32% decrease from the 52 week high of $ 7.34 and a 13.04% increase over the 52 week low of $ 3.68.

ICL belongs of the Basic Industries field, which consists of firms such as Monsanto Firm (MON) and also Syngenta AG (SYT ). ICL’s present revenues each share, an indication of a company’s earnings, is $ .29. Zacks Investment Study reports ICL’s anticipated profits development in 2016 as -37.27%, as compared to an industry standard of 5.6%.

To learn more on the affirmation, document as well as payment dates, see the ICL Reward History web page. Our Dividend Schedule has the full checklist of stocks that have an ex-dividend today.

Interested in gaining direct exposure to ICL via an Exchange Traded Fund

[ETF]
The complying with ETF( s) have ICL as a top-10 holding:

  • iShares MSCI Israel Capped Investable Market Index Fund (EIS )
  • PowerShares Global Agriculture Portfolio (PAGG )
  • VanEck Vectors Israel ETF (ISRA )
  • Guggenheim S&P Global Water (CGW ).

The top-performing ETF of this group is CGW with a boost of 14.66% over the last ONE HUNDRED days. EIS has the highest possible percent weighting of ICL at 2.62%.

The views and viewpoints shared here are the sights as well as point of views of the writer as well as do not always mirror those of Nasdaq, Inc.

Plantations International Monsanto News

By | 2018-07-21T02:47:48+00:00 June 5th, 2016|Categories: Monsanto|Tags: , , , , , |0 Comments